What Is Social Anxiety Disorder? Symptoms, Causes, and Evidence-Based Treatment

Social anxiety disorder (SAD), also known as social phobia, is a clinically recognized mental health condition characterized by an intense, persistent fear of social or performance situations in which the person believes they will be negatively evaluated, embarrassed, or humiliated.

This fear is out of proportion to any realistic threat, leads to avoidance of or distress in social situations, and significantly impairs functioning in work, education, or personal relationships.

The DSM-5 classifies social anxiety disorder as an anxiety disorder with specific diagnostic criteria, and it is one of the most common psychiatric conditions worldwide.

An estimated 7.1% of U.S. adults — approximately 15 million people — experience social anxiety disorder in any given year, and 12.1% will develop it at some point in their lifetime (National Institute of Mental Health [NIMH], 2025).

Despite its prevalence and treatability, a striking 36% of people with SAD report experiencing symptoms for 10 or more years before seeking help (Anxiety and Depression Association of America [ADAA], 2022).

Social anxiety disorder is not shyness. It is a treatable psychiatric condition with well-established, evidence-based psychotherapies and medications that produce meaningful, lasting symptom reduction.

Highlights

 ▸  7.1% of U.S. adults — about 15 million people — have social anxiety disorder in any given year, and 12.1% will develop it at some point in their lives (NIMH, 2025).

  ▸  36% of people with SAD wait 10 or more years before seeking professional help, making it one of the most undertreated of all common psychiatric conditions (ADAA, 2022).

  ▸  Global prevalence of SAD among adolescents is 8.3% and rises to 17% in youth ages 18–24, according to a 2024 systematic review and meta-analysis of 38 studies across 204 countries (Salari et al., 2024).

  ▸  The global incidence of anxiety disorders in young people increased by 52% between 1990 and 2021, with bullying victimization identified as one of the strongest modifiable risk factors (Bie et al., 2024).

  ▸  Cognitive-behavioral therapy (CBT) produces large effect sizes in both individual and telehealth formats (Hedges’ g = 0.90–0.95), with all delivery formats showing significant efficacy in a 2024 systematic review and meta-analysis of 37 RCTs (Wootton, 2025).

  ▸  Safety behaviors — seemingly helpful actions like rehearsing sentences or avoiding eye contact — are a key maintenance mechanism of SAD that prevent the brain from updating its threat model and are specifically targeted in CBT.

  ▸  Approximately 29.9% of U.S. adults with SAD experience serious impairment, and 38.8% experience moderate impairment, meaning fewer than one-third have mild presentations (NIMH, 2025).

What Is Social Anxiety Disorder?

Social anxiety disorder is a persistent mental health condition in which the central fear is negative evaluation by others — being judged, embarrassed, humiliated, or found inadequate in social or performance situations.

The key feature distinguishing SAD from ordinary shyness or social discomfort is the disproportionality of the fear relative to the actual threat, the functional impairment it causes, and its chronicity — the DSM-5 requires symptoms to persist for at least six months for a diagnosis in adults.

Social anxiety disorder is equally common in men and women in the United States, though it typically begins around age 13 (NIMH, 2025). In youth ages 18–24, global prevalence rises to 17% — higher than in either children (4.7%) or adolescents (8.3%) — reflecting the intensification of social demands during this developmental period (Salari et al., 2024).

The disorder tends to follow a chronic course when untreated, and it frequently precedes the development of depression, with longitudinal research showing that SAD increases the risk of subsequent major depressive disorder.

A critical diagnostic distinction is that SAD is not the same as introversion or shyness. Introverts and shy individuals prefer limited social contact but do not experience the intense fear, anticipatory dread, or functional impairment characteristic of SAD.

Approximately 18% of people who exceed the diagnostic threshold for SAD do not self-identify as having the disorder, because they attribute their experiences to “just being shy” or perceive their avoidance as a personal failing rather than a treatable condition (Jefferies & Ungar, 2020).

What Are the Types of Social Anxiety Disorder?

The two DSM-5 specifier types of social anxiety disorder are generalized social anxiety disorder (G-SAD) and performance-only social anxiety disorder (P-Only SAD). These distinctions reflect the breadth of social situations that trigger fear and avoidance, and have implications for treatment approach and prognosis.

Generalized Social Anxiety Disorder

Generalized SAD is characterized by intense fear and avoidance across most social situations — including everyday interactions such as conversations, making phone calls, eating in public, meeting new people, or attending social gatherings. It is the most common and impairing presentation, associated with greater overall functional impairment, higher rates of co-occurring depression and other anxiety disorders, and more pronounced social isolation. Most clinical trials and treatment guidelines address generalized SAD as the primary focus of intervention. Generalized SAD is also more likely to be associated with the cognitive maintaining factors described below — particularly self-focused attention, safety behaviors, and post-event processing.

Performance-Only Social Anxiety Disorder

Performance-only SAD is limited to situations involving public performance — such as public speaking, performing music, acting on stage, or delivering presentations — and does not extend to general social interactions. People with this presentation typically function normally in interpersonal settings but experience intense anticipatory anxiety, physical symptoms, and avoidance specifically around performance demands. The DSM-5 distinguishes this specifier because it carries a somewhat different prognosis and may respond to targeted interventions — including exposure-based CBT and, in some cases, adjunctive use of beta-blockers (which reduce physical symptoms such as heart pounding and trembling) for situational performance anxiety.

What Are the Symptoms of Social Anxiety Disorder?

The symptoms of social anxiety disorder span three domains: cognitive (thoughts and beliefs), physical (bodily responses), and behavioral (actions and avoidance). The full symptom profile is what differentiates SAD from situational nervousness. People with SAD experience these symptoms consistently across social contexts, not just in high-stakes situations, and the symptoms cause meaningful interference with daily functioning.

Cognitive Symptoms

• Fear of negative evaluation: A persistent, overactive concern about how one is being judged by others — expecting scrutiny, mockery, or rejection even in neutral interactions.
• Self-focused attention: Directing awareness inward during social situations (monitoring voice, blushing, word choices) rather than engaging with the conversation or task. This self-monitoring intensifies perceived symptoms and reduces performance.
• Probability and cost bias: Overestimating the likelihood of negative social outcomes (probability bias) and catastrophizing their consequences (cost bias) — predicting that a small social misstep will result in permanent social rejection or humiliation.
• Post-event processing: Replaying social encounters afterward in search of mistakes, errors, or signs of embarrassment — a ruminative process that inflates perceived failure and raises anticipatory anxiety before the next social event.
• Negative self-image: Holding a mental image of oneself in social situations as performing poorly, appearing anxious, or being unlikable — often more distorted and negative than how others actually perceive one.

Physical Symptoms

• Rapid or pounding heartbeat during or before social encounters.
• Sweating, particularly of the palms, underarms, or forehead.
• Trembling or shaking — of the hands, voice, or body — that the person fears will be visible to others.
• Blushing: reddening of the face or neck that is experienced as intensely embarrassing and which increases self-consciousness.
• Dry mouth, throat tightness, or difficulty swallowing — particularly in performance situations.
• Nausea, stomach discomfort, or the urge to use the restroom before or during social events.
• Dizziness or lightheadedness during acute social anxiety episodes.

Behavioral Symptoms

• Avoidance: Declining or withdrawing from social situations, gatherings, interviews, events, or interactions that trigger anxiety. Avoidance is the most functionally impairing behavior and is the primary mechanism by which SAD maintains and deepens over time.
• Safety behaviors: Actions taken during social situations to reduce anxiety or prevent feared outcomes — including over-preparing what to say, gripping objects, avoiding eye contact, not speaking in groups, or wearing concealing clothing to hide blushing. Safety behaviors appear helpful, but actually prevent the person from learning that the feared catastrophe will not occur, maintaining the disorder.
• Endurance with distress: When outright avoidance is not possible, the person endures social situations with intense anxiety, which limits their ability to engage, learn, and build confidence.

Social Anxiety in Children

In children, social anxiety disorder may present differently from adults: symptoms often manifest as crying, tantrums, clinging to caregivers, or refusing to attend school. Children may not be able to articulate their fear of negative evaluation, but will show behavioral avoidance of speaking in class, participating in group activities, or joining peer interactions. The DSM-5 specifies that in children, anxiety must occur in peer settings — not only in adult interactions — for a SAD diagnosis.

How Does Social Anxiety Disorder Maintain Itself Over Time?

Social anxiety disorder maintains itself over time through a well-characterized cycle of cognitive and behavioral processes — not simply because the person is shy or avoidant. Understanding these maintenance factors is clinically important because they are directly targeted in evidence-based treatment. The table below summarizes the key maintaining mechanisms of SAD.

Maintaining Factor	What It Looks Like	Why It Keeps SAD Going
Self-focused attention	Monitoring voice trembling, blushing, or perceived awkwardness	Diverts attention from task, increases perceived symptoms
Safety behaviors	Rehearsing sentences; avoiding eye contact; gripping objects	Prevent disconfirming feared catastrophe; reinforce the belief that the anxiety is dangerous
Post-event processing	Replaying conversation flaws for hours/days after	Inflates sense of failure; elevates anxiety before next social encounter
Anticipatory anxiety	Dreading events days in advance	Primes nervous system; increases avoidance motivation
Avoidance	Cancelling plans; not applying for promotion	Prevents new learning; deprives person of disconfirming evidence

The cognitive model of SAD, most thoroughly described by Clark and Wells (1995) and Heimberg and colleagues, proposes that when a person with SAD enters a social situation, they shift their attention inward — monitoring internal sensations such as blushing or a trembling voice — and construct an image of themselves as they believe they appear to others. This image is typically far more negative and conspicuous than the actual external appearance. The heightened self-focus and distorted negative self-image combine with safety behaviors and post-event rumination to prevent the disconfirmation of feared outcomes, keeping the cycle active indefinitely without intervention.

A 2024 randomized controlled trial found that mindfulness-combined CBT (M-CBT) produced significant improvements in probability bias, fear of negative evaluation, and depressive symptoms in individuals with high social anxiety — with effect sizes in the moderate-to-large range (Noda et al., 2024). The addition of mindfulness components to standard CBT is now recognized as a clinically meaningful enhancement, particularly for individuals who have difficulty with cognitive restructuring alone.

What Causes Social Anxiety Disorder?

The causes of social anxiety disorder are multifactorial — involving an interaction between genetic vulnerability, neurobiological differences, developmental experiences, and social-environmental factors. No single cause explains all cases, and the disorder typically develops from a convergence of biological predisposition and triggering life experiences.

Genetic and Biological Factors

Social anxiety disorder runs in families, with first-degree relatives of people with SAD at significantly elevated risk of developing the condition. Twin studies suggest a heritability estimate of approximately 30–40%, indicating a meaningful but not deterministic genetic contribution. At the neurobiological level, SAD is associated with hyperreactivity of the amygdala (the brain’s primary threat-detection and fear-response center) to social threat cues such as critical or neutral facial expressions. fMRI studies show that effective CBT produces measurable changes in amygdala-prefrontal connectivity — specifically, strengthened inverse connectivity between the amygdala and the dorsomedial prefrontal cortex (a region involved in social cognition and self-monitoring) — and that these neural changes at the end of treatment predict superior outcomes 6–12 months later (PMC, 2020). This neuroimaging evidence confirms that successful psychotherapy produces lasting changes in the brain circuits driving the disorder.

Developmental and Environmental Factors

Adverse social experiences during development significantly increase SAD risk. These include:

• Bullying, teasing, or ridicule from peers — identified as one of the strongest modifiable risk factors in a 2024 GBD analysis of 204 countries (Bie et al., 2024).
• Overprotective or overly critical parenting styles that increase self-consciousness and reduce the child’s opportunities to develop social confidence through direct experience.
• Behavioral inhibition in early childhood — a temperamental pattern of withdrawal in response to novelty — which is a documented risk factor for later anxiety disorders including SAD.
• Traumatic social experiences — including public humiliation, romantic rejection, or severe performance failures — that condition intense fear responses to similar situations.

Social Media and Technological Factors

A significant contemporary contributing factor is the rise of social media and digital communication. Because social media provides social connection without requiring direct face-to-face interaction, heavy reliance on digital platforms reduces the development of in-person social skills and confidence — particularly in children and adolescents during sensitive developmental periods. The global incidence of anxiety disorders in young people (ages 10–24) increased by 52% between 1990 and 2021, with rates accelerating sharply after 2019 — a period coinciding with intensified social media use and, subsequently, the COVID-19 pandemic’s disruption of in-person social interaction (Bie et al., 2024). Clinicians increasingly report that younger patients with SAD have reduced in-person social experience as a contributing factor.

What Mental Health Conditions Co-Occur With Social Anxiety Disorder?

Social anxiety disorder co-occurs with other mental health conditions at high rates — a pattern clinicians describe as comorbidity (the simultaneous presence of two or more diagnosable conditions). Understanding comorbidities is clinically essential because they affect treatment planning, prognosis, and the level of care needed.

• Major depressive disorder (MDD): SAD is one of the strongest predictors of subsequent depression. The social isolation, avoidance of opportunities, and chronic negative self-evaluation that characterize SAD create direct pathways to hopelessness and depressed mood. A substantial proportion of people seeking treatment for depression have an unrecognized underlying social anxiety disorder.
• Generalized anxiety disorder (GAD): GAD involves excessive, difficult-to-control worry across multiple life domains (not only social ones), and commonly co-occurs with SAD. The distinction is that GAD worry extends to finances, health, work, and global events, whereas SAD anxiety is specifically triggered by social evaluation contexts.
• Panic disorder: Some individuals with SAD develop panic attacks in social situations — producing a secondary fear of the panic response itself. SAD with comorbid panic disorder is associated with greater functional impairment and may require a more intensive treatment approach.
• Substance use disorders: Alcohol and other substances are frequently used as self-medication to reduce social anxiety — allowing the person to engage in social situations they would otherwise avoid. This pattern is particularly common in SAD because alcohol’s acute anxiolytic (anxiety-reducing) effects make it reinforcing in social contexts. Over time, dependence develops and the substance use compounds functional impairment.
• Avoidant personality disorder (AvPD): SAD and AvPD share considerable overlap in symptoms and are sometimes conceptualized as different severity levels of the same underlying condition rather than categorically distinct disorders. AvPD involves more pervasive patterns of social inhibition, feelings of inadequacy, and hypersensitivity to negative evaluation that extend across most life contexts from an early age.
• ADHD: ADHD (attention deficit hyperactivity disorder) can co-occur with SAD. The two conditions share some surface-level features — such as social difficulties and underperformance in academic or occupational settings — but differ fundamentally: ADHD is driven by inattention and executive function impairment, while SAD is driven by fear of negative evaluation. Treatment approaches are distinct, and accurate differential diagnosis is necessary to direct the most effective intervention.

How Is Social Anxiety Disorder Diagnosed?

Social anxiety disorder is diagnosed through a clinical evaluation by a licensed mental health or medical professional using DSM-5 criteria. There is no laboratory test or brain scan for SAD; diagnosis rests on a thorough psychiatric interview assessing the presence, duration, and functional impact of symptoms.

DSM-5 diagnostic criteria for SAD require all of the following:

1. A marked fear or anxiety about one or more social situations involving potential scrutiny by others — such as conversations, being observed while eating, or performing in front of others.
2. The person fears they will act in a way, or show anxiety symptoms, that will be negatively evaluated by others.
3. The social situation almost always provokes fear or anxiety — not occasionally or only in specific high-stakes settings.
4. The feared social situations are avoided or endured with intense fear or anxiety.
5. The fear or anxiety is out of proportion to the actual threat posed by the situation, taking into account the sociocultural context.
6. The symptoms have persisted for at least six months.
7. The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning.
8. The symptoms are not attributable to substance use, a medical condition, or better explained by another mental disorder.

In clinical practice, structured or semi-structured interview tools — including the Structured Clinical Interview for DSM-5 (SCID-5) or the Liebowitz Social Anxiety Scale (LSAS) — improve diagnostic accuracy and help quantify severity. A 2025 study found that the LSAS’s total score and subscale responses were the most informative predictors of CBT treatment response — more than demographic variables, psychiatric history, or other clinical scales (Bukhari et al., 2025). This finding has direct clinical utility: baseline LSAS scores can help both clinicians and patients anticipate the expected trajectory of CBT.

What Are the Evidence-Based Treatments for Social Anxiety Disorder?

Evidence-based treatments for social anxiety disorder are specific psychotherapeutic and pharmacological approaches validated in randomized controlled trials to produce significant, lasting reductions in social anxiety symptoms, fear of negative evaluation, avoidance behavior, and functional impairment. A 2024 systematic review and meta-analysis of 37 RCTs covering 3,234 participants confirmed that all major CBT delivery formats produce significant effects compared to control conditions, with a pooled effect size of Hedges’ g = 0.87 (Wootton, 2025).

Format	Effect Size (Hedges’ g)	Best For	Key Advantage
Individual CBT (ICBT)	Large (g = 0.95)	Severe SAD; high comorbidity	Personalized pacing; tailored exposures
Remote/Telehealth CBT (RCBT)	Large (g = 0.90)	Access barriers; rural/housebound patients	Equal efficacy to in-person; greater flexibility
Group CBT (GCBT)	Medium (g = 0.61)	Mild-to-moderate SAD; interpersonal component	Peer normalisation; exposure in social setting
Mindfulness-based CBT (M-CBT)	Moderate-to-large (ds=0.51–1.55)	SAD with high probability/cost bias	Enhances cognitive flexibility; reduces self-focused attention

Cognitive-Behavioral Therapy (CBT)

CBT is the gold-standard first-line psychotherapy for social anxiety disorder, recommended by the National Institute for Health and Care Excellence (NICE), the American Psychological Association (APA), and all major clinical practice guidelines. CBT for SAD primarily targets the cognitive and behavioral maintaining mechanisms of the disorder rather than the anxiety itself.

The core components of CBT for SAD include:

• Cognitive restructuring: Identifying and systematically challenging automatic negative thoughts about social situations, including probability bias (overestimating the chance of negative outcomes) and cost bias (catastrophizing their consequences).
• Exposure therapy: Gradual, systematic confrontation with feared social situations — in-session, in real life (in vivo), and increasingly through virtual reality platforms — that provides corrective learning experiences disconfirming the feared outcome. Exposure works by activating and then failing to reinforce the threat prediction, allowing the brain to update its fear model.
• Elimination of safety behaviors: Deliberately dropping safety behaviors during exposures (such as avoiding eye contact, over-preparing scripts, or gripping objects) is now recognized as essential for exposures to produce maximum learning. Safety behavior elimination is specifically targeted in Clark and Wells’ cognitive therapy model for SAD.
• Self-focused attention retraining: Exercises that redirect attention outward — toward the task, conversation, or environment — rather than inward toward self-monitoring. Attention retraining directly disrupts a core maintaining factor of the disorder.
• Post-event processing reduction: CBT includes specific techniques for interrupting the post-event rumination cycle, including scheduled review periods, behavioral experiments to test accuracy of post-event memories, and mindfulness-based techniques.

Acceptance and Commitment Therapy (ACT)

ACT is a third-wave behavioral therapy that approaches social anxiety from the perspective of psychological flexibility rather than symptom reduction. Rather than challenging negative thoughts directly, ACT teaches individuals to accept the presence of anxiety without being behaviorally governed by it — committing to value-consistent actions even when anxiety is present. A growing body of research supports ACT’s efficacy for SAD, particularly for individuals who have not responded fully to CBT or who struggle with cognitive restructuring approaches. Neuroimaging research indicates that both CBT and ACT produce similar patterns of change in amygdala-prefrontal connectivity — suggesting overlapping mechanisms of therapeutic action at the neural level (PMC, 2020).

Pharmacotherapy

Medication is an effective option for SAD, either as a standalone treatment or in combination with psychotherapy. The primary pharmacological options are:

• SSRIs (selective serotonin reuptake inhibitors): Paroxetine and sertraline are FDA-approved for social anxiety disorder and are considered first-line medication treatments. SSRIs work by increasing the availability of serotonin (a neurotransmitter involved in mood regulation, fear processing, and social behavior) in brain circuits that mediate anxiety responses.
• SNRIs (serotonin-norepinephrine reuptake inhibitors): Venlafaxine extended-release is also FDA-approved for SAD and works by increasing both serotonin and norepinephrine (a neurotransmitter involved in alertness and stress responses) availability. SNRIs are particularly useful when SAD co-occurs with depression.
• Beta-blockers: Propranolol reduces the physical symptoms of performance anxiety (heart pounding, trembling, sweating) and is used situationally for performance-only SAD in specific high-stakes settings. It is not a first-line treatment for generalized SAD and does not address the underlying cognitive mechanisms.
• Benzodiazepines: Benzodiazepines (such as lorazepam or clonazepam) produce rapid anxiolytic effects but are not recommended as long-term treatment for SAD due to tolerance, dependence risk, and the absence of benefit to the cognitive maintaining factors of the disorder. Short-term use may be considered under specific clinical circumstances.

What Is the Difference Between Shyness and Social Anxiety Disorder?

Shyness and social anxiety disorder are related but clinically distinct. Shyness is a personality trait — a tendency to feel hesitant or uncomfortable in social situations that does not typically cause significant functional impairment or persistent distress. Many shy people navigate social situations with modest discomfort and function well across their life domains. Social anxiety disorder, by contrast, involves an intensity and chronicity of fear that causes clinically significant impairment and that the person often cannot resolve through effort, social skill practice, or willpower alone.

The key clinical distinctions are:

• Intensity: Shyness involves mild-to-moderate discomfort; SAD involves intense, often overwhelming fear.
• Impairment: Shyness rarely prevents people from pursuing career goals, friendships, or relationships; SAD frequently does.
• Pervasiveness: Shyness may be limited to specific contexts (like meeting strangers); SAD is triggered consistently across most social situations (in generalized SAD) or performance settings.
• Physical response: Shyness causes mild self-consciousness; SAD triggers a full physiological fear response, including racing heart, sweating, trembling, and panic-level distress.
• Duration: Shyness may fade with familiarity; SAD symptoms persist for at least six months and do not diminish through mere exposure without structured treatment.

When Should You Seek Professional Help for Social Anxiety Disorder?

You should seek professional help for social anxiety disorder when fear of social situations is causing you to avoid important activities, miss opportunities, or experience significant distress that is not resolving on its own. The average person with SAD waits more than 10 years before seeking treatment — a delay that allows the disorder to deepen, comorbidities to develop, and functional impairment to compound. No severity threshold must be met before seeking evaluation: even mild-to-moderate SAD is highly treatable, and earlier intervention consistently produces better outcomes.

Indicators that professional evaluation is warranted include:

9. Avoiding work presentations, social events, telephone calls, or interactions to the point that career or relationships are affected.
10. Experiencing intense physical symptoms (heart pounding, sweating, shaking) during or before social situations — even routine ones.
11. Spending significant time before or after social events in anticipatory anxiety or post-event rumination.
12. Using alcohol or other substances to manage social anxiety.
13. Declining educational, professional, or personal opportunities because of social fear.
14. Children refusing school attendance, declining peer activities, or showing consistent distress in group settings.

Seek urgent evaluation when:

• SAD is accompanied by suicidal thoughts — both SAD and its frequent comorbidity with depression elevate suicide risk.
• Social anxiety has become so severe that the person is largely housebound, unable to maintain employment, or socially isolated to a degree that basic functioning is compromised.
• There has been escalating substance use, particularly alcohol, to manage social fear.

How Can You Support Someone With Social Anxiety Disorder?

Supporting a loved one with SAD requires understanding that the avoidance behaviors and social withdrawal that define the disorder are symptoms — not personality defects, laziness, or rudeness. The most effective support combines patient encouragement with informed understanding of how SAD works.

• Avoid accommodating avoidance: Reassuring the person that they do not need to attend events, making excuses on their behalf, or removing social demands may provide short-term relief but reinforces avoidance long-term. Gentle, consistent encouragement to engage with feared situations — at a pace they can manage — is more aligned with recovery.
• Do not minimize: Saying “just relax,” “there’s nothing to be scared of,” or “everyone gets nervous” dismisses the clinical reality of the disorder. SAD is not a matter of willpower or perspective that can be resolved by thinking positively.
• Educate yourself: Understanding the cognitive maintaining cycle of SAD — particularly the role of safety behaviors and post-event processing — helps family members respond in ways that support rather than inadvertently reinforce the disorder.
• Encourage evidence-based treatment: Gently and consistently encourage professional evaluation and CBT-based treatment. Normalize therapy as effective medical care rather than a sign of weakness or severity.
• Seek your own support if needed: Living with or caring for someone with severe SAD can be isolating and frustrating. Individual therapy and ADAA’s online support community (adaa.org) provide resources for family members and partners.

What Should You Do Next?

Social anxiety disorder is highly treatable. The evidence base for CBT — including individual, group, telehealth, and mindfulness-enhanced formats — is among the most robust of any mental health condition. A 2024 network meta-analysis of 92 studies confirmed that all major psychotherapies produce significant symptom reductions compared to control conditions, and that treatment gains are durable over time (Springer meta-analysis, 2022). Medication with SSRIs or SNRIs is an equally validated option for those who prefer pharmacological treatment or who have not responded to psychotherapy alone.

If you are concerned about yourself or someone you care about:

15. Contact a licensed therapist or psychologist with experience in CBT for anxiety disorders — specifically ask about their experience with exposure therapy for SAD and whether they address safety behaviors and post-event processing.
16. Use the ADAA therapist finder (adaa.org/find-help) or Psychology Today’s directory (psychologytoday.com) to filter by social anxiety and CBT specialization.
17. Contact a psychiatrist or primary care physician if medication is being considered, or if an initial evaluation is needed before beginning therapy.
18. For telehealth options, remote CBT has demonstrated large effects (g = 0.90) equivalent to in-person formats, making it a fully legitimate first-line option for those with access barriers.

Talk to a healthcare provider who specializes in cognitive-behavioral therapy for anxiety disorders to determine the treatment format and intensity that best matches the current severity and life circumstances.

References

Anxiety and Depression Association of America (ADAA). (2022). Social anxiety disorder facts and statistics. https://adaa.org/understanding-anxiety/social-anxiety-disorder/social-anxiety-facts-statistics

Bie, Y., Yan, S., Xing, J., Wang, S., Xu, Y., Wang, Z., Wang, G., Guo, Y., Qiao, Y., & Rao, G. (2024). Rising global burden of anxiety disorders among adolescents and young adults: Trends, risk factors, and the impact of socioeconomic disparities and COVID-19 from 1990 to 2021. Frontiers in Psychiatry, 15, 1489427. https://doi.org/10.3389/fpsyt.2024.1489427

Bukhari, Q., Rosenfield, D., Hofmann, S. G., Gabrieli, J. D. E., & Ghosh, S. S. (2025). Predicting treatment response to cognitive behavior therapy in social anxiety disorder on the basis of demographics, psychiatric history, and scales: A machine learning approach. PLOS ONE, 20(3), e0313351. https://doi.org/10.1371/journal.pone.0313351

Clark, D. M., & Wells, A. (1995). A cognitive model of social phobia. In R. G. Heimberg, M. R. Liebowitz, D. A. Hope, & F. R. Schneier (Eds.), Social phobia: Diagnosis, assessment, and treatment (pp. 69–93). Guilford Press.

Jefferies, P., & Ungar, M. (2020). Social anxiety in young people: A prevalence study in seven countries. PLOS ONE, 15(9), e0239133. https://doi.org/10.1371/journal.pone.0239133

National Institute of Mental Health (NIMH). (2025). Social anxiety disorder statistics. https://www.nimh.nih.gov/health/statistics/social-anxiety-disorder

Noda, Y., Sato, M., Uehara, T., & Tomita, M. (2024). Efficacy of a mindfulness and CBT combined program (M-CBT) for social anxiety: A randomized controlled trial. BMC Psychiatry, 24, 190. https://doi.org/10.1186/s12888-024-05651-0

PMC (National Center for Biotechnology Information). (2020). Changes in functional connectivity with cognitive behavioral therapy for social anxiety disorder predict outcomes at follow-up. Frontiers in Psychiatry. https://pmc.ncbi.nlm.nih.gov/articles/PMC7329578/

Salari, N., Heidarian, P., Hassanabadi, M., Babajani, F., Abdoli, N., Aminian, M., & Mohammadi, M. (2024). Global prevalence of social anxiety disorder in children, adolescents and youth: A systematic review and meta-analysis. Journal of Prevention, 45(5), 795–813. https://doi.org/10.1007/s10935-024-00789-9

Wootton, B. M. (2025). Cognitive behaviour therapy for social anxiety disorder: A systematic review and meta-analysis investigating different treatment formats. Australian Psychologist, 60(1), 1–14. https://doi.org/10.1080/00050067.2024.2356804

Zhang, J., & Lin, Y. (2024). The efficacy of web-based cognitive behavioral therapy for social anxiety disorder: A randomized controlled trial. JMIR Mental Health, 11, e50535. https://doi.org/10.2196/50535